REG - Aberdeen Equity Inc - Compliance with Market Abuse Regulation

Aberdeen Equity Income TrustAnnouncement

28/04/2026 12:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260428:nRSb2506Ca&default-theme=true

RNS Number : 2506C  Aberdeen Equity Income Trust plc  28 April 2026

ABERDEEN EQUITY INCOME TRUST PLC (the "Company")

Legal Entity Identifier (LEI): 21380015XPT7BZISSQ74

 

28 April 2026

 

Aberdeen Equity Income Trust plc announces that it is satisfied, by virtue of
the points listed below, that all inside information which the Directors and
the Company may have in the closed period which ends on the date of the
announcement of the Half Yearly Financial Report for the six months ended 31
March 2026 has been notified to a Regulated Information Service ("RIS"). The
Company is therefore not prohibited from dealing in its own securities during
this period.

 

In so stating the Company has regard to:

 

1)   the announcement on 8 April 2026 of the net asset value per share as of
the close of business on 31 March 2026.

2)   the Company's belief, following reasonable enquiries, is that there
will be no material difference between the information published on 8 April
2026 and that to be included in the forthcoming announcement of the Annual
Financial Report.

3)   the Company's practice of calculating net asset values per share each
business day and the announcement of these net asset values to an RIS.

4)   there being no other unpublished information which constitutes
price-sensitive information in respect of the Company's securities; and

5)   there being no unquoted investments within the Company's portfolio.

 

 

For further information, please contact:

Helen Leslie

abrdn Holdings Limited

Secretaries

0131 372 9153

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPPUAGCUPQGGR



            Copyright 2019 Regulatory News Service, all rights reserved